In summary, our study is the first to report that the upregulation of CUL1 inhibits the development of COPD by reducing the secretion of inflammatory cytokines and inhibiting the oxidative stress response through the p53 signaling pathway, demonstrating that CUL1 may be a potential therapeutic target in COPD. The gene discussed is CUL1; the disease is chronic obstructive pulmonary disease.